✦ LIBER ✦

Phase II Study of Efficacy and Safety of Bevacizumab in Combination With Chemotherapy or Erlotinib Compared With Chemotherapy Alone for Treatment of Recurrent or Refractory Non Small-Cell Lung Cancer

✍ Scribed by Herbst, R. S.; O'Neill, V. J.; Fehrenbacher, L.; Belani, C. P.; Bonomi, P. D.; Hart, L.; Melnyk, O.; Ramies, D.; Lin, M.; Sandler, A.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

53 POSTER A phase II, multicenter, rando

✍ R. Herbst; V. O'Neill; L. Fehrenbacher; C. Belani; P. Bonomi; L. Hart; O. Melnyk 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 59 KB

A phase II study of erlotinib in combina

✍ Ciuleanu, T.; Tsai, C.-M.; Tsao, C.-J.; Milanowski, J.; Amoroso, D.; Heo, D.S.; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 718 KB

Phase II study of docetaxel and ifosfami

✍ Chen, Y 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 103 KB

130 POSTER Phase II trial of Sequenced B

✍ E. Cohen; R. Govindan; M. Kozloff; A. Mauer; P. Hoffman; T. Karrison; J. Stein; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 73 KB

Pilot phase II study of weekly chemother

✍ Kiyoshi Mori; Yukari Kamiyama; Tetsuro Kondo; Yasuhiko Kano; Tetsuro Kodama 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 192 KB

Phase II study of docetaxel and cisplati

✍ Y. H. Kim; J. S. Kim; Y. H. Choi; K. H. In; H. S. Park; D. S. Hong; T. J. Jeong; 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 67 KB